Development of liquid chromatographic enantiomer separation methods and validation for the estimation of (R)-enantiomer in eslicarbazepine acetate

Journal of Pharmaceutical and Biomedical Analysis

Volumn 54, Issue 1, 2011, Pages 248-251

  Mone, Mahesh Kumar ^a,b   Chandrasekhar, K B ^b  

^a Advinus Therapeutics Private Limited Bangalore   (India)

^b JNTUA COLLEGE OF ENGINEERING   (India)

Author keywords

Chiral stationary phase; Enantiomeric separation; Eslicarbazepine acetate; Licarbazepine; Polar organic solvent chromatography

Indexed keywords

ACETONITRILE; ALCOHOL; CARBAMIC ACID DERIVATIVE; CELLULOSE TRIS (3,5 DICHLOROPHENYLCARBAMATE); DICHLOROMETHANE; ESLICARBAZEPINE ACETATE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CHIRALITY; DRUG STRUCTURE; ENANTIOMER; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SEPARATION TECHNIQUE; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

ACETONITRILES; CHEMISTRY TECHNIQUES, ANALYTICAL; CHEMISTRY, PHARMACEUTICAL; CHLORINE; CHROMATOGRAPHY; CHROMATOGRAPHY, LIQUID; DIBENZAZEPINES; ETHANOL; METHYLENE CHLORIDE; ORGANIC CHEMICALS; REPRODUCIBILITY OF RESULTS; SOLVENTS; STEREOISOMERISM; TEMPERATURE;

EID: 77957020873     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.08.015     Document Type: Article

References (8)

1. Almeida L., Soares-da-Silva P. Eslicarbazepine Acetate (BIA 2-093). Neurotherapeutics: J. Am. Soc. Exp. NeuroTherapeutics 2007, 4:88-96.
2. Parada A., Soares-da-Silva P. The novel anticonvulsant BIA 2-093 inhibits transmitter release during opening of voltage-gated sodium channels: a comparison with carbamazepine and oxcarbazepine. Neurochem. Int. 2002, 40:435-440.
3. Bialer M., White H.S. Key factors in the discovery and development of new antiepileptic drugs. Nat. Rev. Drug Disc. 2010, 9:68-82.
4. Bialer M., Johannessen S.I., Kupferberg H.J., Levy R.H., Perucca E., Tomson T. Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res. 2004, 61:1-48.
5. Hainzl D., Parada A., Soares-da-Silva P. Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine. Epilepsy Res. 2001, 44:197-206.
6. Almeida L., Falcão A., Maia J., Mazur D., Gellert M., Soares-da-Silva P. Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects. J. Clin. Pharmacol. 2005, 45:1062-1066.
7. Alves G., Figueiredo I., Castel-Branco M., Loureiro A., Falco A., Caramona M. Simultaneous and enantioselective liquid chromatographic determination of eslicarbazepine acetate, S-licarbazepine, R-licarbazepine and oxcarbazepine in mouse tissue samples using ultraviolet detection. Anal. Chim. Acta 2007, 596:132-140.
8. IFPMA ICH draft Guidelines on Validation of Analytical Procedures: Definitions and Terminology. Federal Register 1995, vol. 60. IFPMA, Switzerland, pp. 11260-11262.